FDA Issued Emergency Use Authorization to Thermo Fisher Scientific for Diagnostic Test Used to Detect COVID-19 on March 13

Thermo Fisher Scientific Inc. announces that the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories in the U.S. to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19, and not for any other viruses or pathogens.

Please to read the entire article.

You must be logged in to post a comment Login